Copper and nanotechnology The great innovation
Article Sidebar
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Downloads
Main Article Content
Abstract
Can the application of nanotechnology to copper generate a powerful tool to design new materials with antimicrobial properties? Yes. Today it is possible to confer the antimicrobial action of copper to practically any material by selecting the proper nanoparticle and processing of the compound. Plasticopper, a company that is spin-off of the University of Chile, is an example of the sale of these technologies in the design of a series of products with biocidal properties.
Article Details
References
Benadof D., Acuña M., Elgueta A., Cifuentes P., Guajardo P., 2010. “Impacto de la derivación de pacientes de otras instituciones de salud y portación de microorganismos multiresistentes”, afiche Congreso Chileno de Infectología XXVII, Valdivia.
Burke J., 2003. “Infection control-a problem for patient safety”, The New England Journal of Medicine.
Estimating Health Care-Associated Infections and Deaths in US Hospitals, 2002. http://www.cdc.gov/HAI/pdfs/hai/infections_deaths.pdf
Faúndez G., Troncoso M., Navarrete P., Figueroa G., 2004. “Antimicrobial activity of copper surfaces against suspensions of Salmonella enterica and Campylobacter jejuni”, BMC Microbiology.
Gunawan C., Teoh W.Y., Marquis C.P., Amal R., 2011. “Cytotoxic origin of copper(II) oxide nanoparticles: Comparative studies with micron-sized particles, leachate, and metal salts”, ACS Nano.
Huslage K., Rutala W.A., Sickbert-Bennett E., Weber D.J., 2010. “A quantitative approach to defining “high touch” surfaces in hospitals”, Infection Control & Hospital Epidemiology.
Jarvis W., 1994 “Handwashing- the Semmelweis lesson forgotten?”,The Lancet.
Kramer A., Schwebke I., Kampf G., 2006. “How long do nosocomial pathogens persist on inanimate surfaces? A systematic review”, BMC Infectious Diseases.
Lemire J.A., Harrison J.J., Turner R.J., 2013. “Antimicrobial activity of metals: Mechanisms, molecular targets and applications”, Nature Reviews Microbiology.
Martínez J.A., Ruthazer R., Hansjosten K., Barefoot L., Snydman D.R.,2003. “Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit”, Archives of Internal Medicine Journal.
OMS, 2002. Prevention of Hospital-acquired infections. A practical guide. Department of Communicable Disease, 2nd edition.
Otter J.A., Yezli S., French G.L., 2011. “The role played by contaminated surfaces in the transmission of nosocomial pathogens”,Infection Control & Hospital Epidemiology.
Palza H., 2015. “Antimicrobial Polymers with Metal Nanoparticles”, International Journal of Molecular Science.Palza H., Gutiérrez S., Delgado K., Salazar O., Fuenzalida V., Avila J., Figueroa G., Quijada R., 2010. “Toward tailor-made biocide materials based on polypropylene/copper nanoparticles”, Macromolecular Rapid Communications.
Siempos I., Kopetrides P., 2009. “Impact of catheter related bloodstream infections on the mortality of critically ill patients: a metanalysis”, Critical Care Medicine.
Wilks S.A., Michels H., Keevil C.W., 2005. “The survival of Escherichia coli O157 on a range of metal surfaces”, International Journal of Food Microbiology.